FDA approves new imaging tool to find advanced prostate cancer June 4, 2021 The Food and Drug Administration has approved a new imaging agent to detect prostate cancer after it has spread to other parts of the body.Experts say the tracer, made by medical imaging company Lantheus, will give doctors an important visual aid to guide them to metastatic prostate cancer cells that, before now, were difficult to spot.Read the full article here. About Prostate Cancer Imaging Prostate Cancer News Treatment Options More for you
The Food and Drug Administration has approved a new imaging agent to detect prostate cancer after it has spread to other parts of the body.Experts say the tracer, made by medical imaging company Lantheus, will give doctors an important visual aid to guide them to metastatic prostate cancer cells that, before now, were difficult to spot.Read the full article here.
Complete the Survey
